Zantac on sale over counter
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Glaxo has won approval for over-the-counter sales of its best-selling drug, Zantac, in Britain. The drug, which relieves the symptoms of heartburn and dyspepsia, will be on sale within the first quarter of this year, marketed through Glaxo's alli ance with Warner Wellcome.
The company is seeking regulatory approval for over-the-counter sales of the drug in other countries, including the US.
Busin
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments